|
Drug Interactions The concomitant use of oxybutynin with other anticholinergic drugs or with other agents which produce dry mouth, constipation, somnolence (drowsiness), and/ or other anticholinergic-like effects may increase the frequency and/ or severity of such effects. Anticholinergic agents may potentially alter the absorption of some concomitantly administered drugs due to anti-cholinergic effects on gastrointestinal motility. This may be of concern for drugs with a narrow therapeutic index. Text Continues Below
Mean oxybutynin chloride plasma concentrations were approximately 2 fold higher when DITROPAN XL was administered with ketoconazole, a potent CYP3A4 inhibitor. Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e. g., itraconazole and miconazole) or macrolide antibiotics (e. g., erythromycin and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i. e., Cmax and AUC). The clinical relevance of such potential interactions is not known. Caution should be used when such drugs are co-administered. Carcinogenesis, Mutagenesis, Impairment of Fertility A 24-month study in rats at dosages of oxybutynin chloride of 20, 80, and 160 mg/ kg/ day showed no evidence of car-cinogenicity. These doses are approximately 6, 25, and 50 times the maximum human exposure, based on surface area. Oxybutynin chloride showed no increase of mutagenic activity when tested in Schizosaccharomyces pompholiciformis, Saccharomyces cerevisiae, and Salmonella typhimurium test systems. Reproduction studies with oxybutynin chloride in the mouse, rat, hamster, and rabbit showed no definite evidence of impaired fertility. Pregnancy: Teratogenic Effects Pregnancy Category B Reproduction studies with oxybutynin chloride in the mouse, rat, hamster, and rabbit showed no definite evidence of impaired fertility or harm to the animal fetus. The safety of DITROPAN XL administration to women who are or who may become pregnant has not been established. Therefore, DITROPAN XL should not be given to pregnant women unless, in the judgment of the physician, the probable clinical benefits outweigh the possible hazards. Page: << Prev | 1 | 2 | 3 | Next >>
|
.gif)
